Old Web
English
Sign In
Acemap
>
authorDetail
>
Emmi Vakkila
Emmi Vakkila
Helsinki University Central Hospital
Immunology
Myeloid leukemia
Tyrosine-kinase inhibitor
Dasatinib
Medicine
3
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia
2017
Journal of Pediatric Hematology Oncology
Neda Mosakhani
Mohamed El Missiry
Emmi Vakkila
Sakari Knuutila
Jukka Vakkila
Show All
Source
Cite
Save
Citations (5)
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
2014
European Journal of Haematology
Perttu Koskenvesa
Anna Kreutzman
Peter Rohon
Markus Pihlman
Emmi Vakkila
Anu Räsänen
Mirja Vapaatalo
Kari Remes
Tuija Lundán
Henrik Hjorth-Hansen
Jukka Vakkila
Bengt Simonsson
Satu Mustjoki
Kimmo Porkka
Show All
Source
Cite
Save
Citations (11)
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia
2012
Experimental Hematology
Anna Kreutzman
Taina Jaatinen
Dario Greco
Emmi Vakkila
Johan Richter
Marja Ekblom
Henrik Hjorth-Hansen
Leif Stenke
Teresa Melo
Ron Paquette
Ruth Seggewiss-Bernhardt
Agnès Guerci-Bresler
Alexis Talbot
Jean Michel Cayuela
François-Xavier Mahon
Kimmo Porkka
J H Lipton
Jukka Partanen
Philippe Rousselot
Satu Mustjoki
Show All
Source
Cite
Save
Citations (16)
1